女性盆腔恶性肿瘤患者术中及术后淋巴囊肿预防和治疗的研究进展

doi:10.13481/j.1671-587x.20200436

摘要/Abstract

摘要： 淋巴囊肿是女性盆腔恶性肿瘤术后最常见的并发症之一。选择术中局部应用生物制剂（如纤维蛋白封闭剂、明胶凝血酶基质和氨基丙烯酸正丁酯）、前哨淋巴结活检术、腹膜开放法、网膜成形术、术后应用奥曲肽及术后使用中药大黄、芒硝外敷联合内服等多种方法可降低术后淋巴囊肿的发生率；超声引导下穿刺引流术、中药大黄、芒硝外敷和超声介导下注入硬化剂（乙醇、聚桂醇和博来霉素等）是目前治疗淋巴囊肿的常用方法。此外，饮食调整和手术治疗也是治疗淋巴囊肿行之有效的方法。现总结近年来女性盆腔恶性肿瘤患者术中和术后预防及治疗盆腔淋巴囊肿的多种方法，对比分析其有效性及优缺点，从而总结出降低淋巴囊肿发生率及提高淋巴囊肿治愈率的有效方法，为临床促进淋巴漏口的愈合及预防淋巴囊肿的发生提供参考。

关键词: 女性盆腔恶性肿瘤, 淋巴切除术, 淋巴囊肿, 生物制剂

中图分类号:

R737.3

许沙沙, 王玲, 靖丽娟, 张炜旸, 王博蔚. 女性盆腔恶性肿瘤患者术中及术后淋巴囊肿预防和治疗的研究进展[J]. 吉林大学学报(医学版), 2020, 46(04): 888-893.

参考文献

[1] GASPARRI M L,RUSCITO I,BOLLA D,et al.The efficacy of fibrin sealant patches in reducing the incidence of lymphatic morbidity after radical lymphadenectomy:a meta-analysis[J]. Gynecol Cancer, 2017, 27(6):1283- 1292.
[2] ZIKAN M, FISCHEROVA D, PINKAVOVA I, et al. A prospective study examining the incidence of asymptomatic and symptomatic lymphoceles following lymphadenectomy in patients with gynecological cancer[J]. Gynecol Oncol, 2015, 137(2):291-298.
[3] KIM H C, CHOI C, KIM W Y. Effectiveness of fibrin sealant patch in reducing drain volume after pelvic lymph node dissection in women with gynecologic malignancy[J]. Biomed Res Int, 2017, 2017:3086857.
[4] GRIMM C, POLTERAUER S, HELMY-BADER S, et al. A collagen-fibrin patch for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies:a randomized clinical trial[J]. Gynecol Oncol, 2018, 149(1):140-145.
[5] PRODROMIDOU A, LAVAZZO C, FOTIOU A, et al.The application of fibrin sealant for the prevention of lymphocele after lymphadenectomy in patients with gynecological malignancies:A systematic review and meta-analysis of randomized controlled trials[J].Gynecol Oncol, 2019,153(1):201-208.
[6] KIM Y H,SHIN H J,JU W,et al.Prevention of lymphocele by using gelatin-thrombin matrix as a tissue sealant after pelvic lymphadenectomy in patients with gynecologic cancers:a prospective randomized controlled study[J]. Gynecol Oncol, 2017,28(3):e37.
[7] GALLOTTA V,FANFANI F,ROSSITTO C,et al. A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer[J]. Obstet Gynecol, 2010,203(5):483.e1-483.e6.
[8] BIFULCO G,GIAMPAOLINO P, MORRA I,et al.Synthetic cyanoacrylic glue in the prevention of post-operative lymphocele after pelviclymphadenectomy in patients with uterine malignancies:A prospective, single-blind, preliminary study[J]. Gynecol Oncol, 2014,134(3):556-560.
[9] NⅡKURA H, TSUJI K, TOKUNAGA H, et al. Sentinel node navigation surgery in cervical and endometrial cancer:a review[J]. Jpn J Clin Oncol, 2019, 49(6):495-500.
[10] 刘青, 刘开江. 前哨淋巴结检测技术在早期宫颈癌中的应用[J]. 中国癌症防治杂志, 2019, 11(3):194-198.
[11] FERRAN DINA G, PEDONE ANCHORA L, GALLOTTA V, et al. Can we define the risk of lymph node metastasis in early-stage cervical cancer patients? a large-scale, retrospective study[J]. Ann Surg Oncol, 2017, 24(8):2311-2318.
[12] GORTZAK-UZAN L,JIMENEZ W,NOFECH-MOZES S,et al.Sentinel lymph node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer:Is it time to change the gold standard?[J].Gynecol Oncol,2010,116(1):28-32.
[13] HAUSPY J, BEINER M, HARLEY I, et al. Sentinel lymph nodes in early stage cervical cancer[J]. Gynecol Oncol, 2007, 105(2):285-290.
[14] NⅡKURA H,OKAMOTO S,OTSUKI T,et al.Prospective study of sentinel lymph node biopsy without further pelvic lymphadenectomy in patients with sentinel lymph node-negative cervical cancer[J]. Gynecol Cancer, 2012,22(7):1244-1250.
[15] SALVO G, RAMIREZ P T, LEVENBACK C F, et al. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer[J]. Gynecol Oncol, 2017, 145(1):96-101.
[16] KUSHNER D M, CONNOR J P, WILSON M A, et al. Laparoscopic sentinel lymph node mapping for cervix cancer:a detailed evaluation and time analysis[J]. Gynecol Oncol, 2007, 106(3):507-512.
[17] SUZUKI M,OHWADA M, SATO I.Pelvic lymphocysts following retroperitoneal lymphadenectomy:retroperitoneal partial"no-closure"for ovarian and endometrial cancers[J]. J Surg Oncol, 1998, 68(3):149-152.
[18] 王延洲,梁志清.妇科恶性肿瘤盆腔淋巴清扫后淋巴囊肿处理[J].中国实用妇科与产科杂志,2016,32(11):1052-1057.
[19] 顾永忠, 张向宁. 妇科盆腔淋巴结清扫术后淋巴囊肿的防治[J]. 中国实用妇科与产科杂志, 2008, 24(9):712-714.
[20] 吴科, 李雨聪, 唐郢. 腹腔镜根治性子宫切除联合盆腔淋巴清扫术后是否放置引流对盆腔淋巴囊肿的影响[J]. 中国微创外科杂志, 2016, 16(12):1089-1091, 1095.
[21] FRANCHI M,TRIMBOS J B,ZANABONI F,et al.Randomised trial of drains versus no drains following radical hysterectomy and pelvic lymph no de dissection:a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG)study in 234 patients[J].Eur J Cancer,2007, 43(8):1265-1268.
[22] CHAROENKWAN K,KIETPEERAKOOL C.Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in women with gynaecological malignancies[J/OL].Cochrane Database Syst Rev,2010.DOI:10.1002/14651858/CD007387.
[23] 代俊利, 李杰, 杨松梅, 等. 中药外敷加口服治疗宫颈癌盆腔淋巴结清扫术后淋巴液渗出及预防淋巴囊肿形成的研究[J]. 临床和实验医学杂志, 2015, 14(18):1504-1507.
[24] WEINBERGER V,MINAR L,FELSINGER M,et al.Postoperative administration of octreotide to reduce lymphorrhea, lymphocele, lymphedema and lymphatic ascites after lymphadenectomy for gynecological malignancies[J].Ceska Gynekol,2017,82(2):92-99.
[25] 李培全,刘青,刘开江,等.妇科恶性肿瘤腹腔镜淋巴结清扫术后淋巴漏的影响因素及治疗方法[J].中国内镜杂志,2018,24(12):43-49.
[26] KUBOKI S, SHIMIZU H, YOSHIDOME H, et al. Chylous ascites after hepatopancreatobiliary surgery[J]. Br J Surg, 2013, 100(4):522-527.
[27] WENIGER M, D'HAESE J G, ANGELE M K, et al. Treatment options for chylous ascites after major abdominal surgery:a systematic review[J]. Am J Surg, 2016, 211(1):206-213.
[28] 侯克刚,茅菲,何姣燕,等.大黄芒硝外敷治疗宫颈癌术后盆腔淋巴囊肿的临床价值研究[J].中华中医药学刊,2020,38(6):109-111.
[29] 李峰, 邓辉. 大黄、芒硝外敷预防盆腔淋巴结清扫术后淋巴囊肿[J]. 四川中医, 2006, 24(5):82.
[30] 孙园园, 巩雪, 于铭, 等. 超声引导下置管引流术治疗盆腔恶性肿瘤术后淋巴囊肿的临床应用价值[J]. 影像诊断与介入放射学, 2015, 24(1):80-82.
[31] 潘明霞,王颖梅, 闫晔,等.子宫内膜癌患者术后盆腔淋巴囊肿感染相关因素及最佳引流时间[J].中华医学杂志, 2017, 97(23):1765-1768.
[32] KAWAMURA I, HIRASHIMA Y, TSUKAHARA M, et al. Microbiology of pelvic lymphocyst infection after lymphadenectomy for malignant gynecologic tumors[J]. Surg Infect (Larchmt), 2015, 16(3):244-246.
[33] 金宏江,周剑宇.超声介入在妇科恶性肿瘤术后盆腔淋巴囊肿治疗中的价值[J]. 中国妇幼健康研究, 2014, 25(5):831-833.
[34] 寇育红.超声介入疗法治疗盆腔淋巴囊肿的效果观察[J]. 临床研究, 2017, 25(4):42-43.
[35] 许志辉.超声引导下介入疗法治疗盆腔恶性肿瘤术后淋巴囊肿的效果与安全性分析[J].中国超声医学杂志,2019,35(6):528-530.
[36] 曹培勇, 周丽, 鲁娟, 等. 大黄芒硝外敷联合超声介入治疗宫颈癌术后盆腔淋巴囊肿疗效观察[J]. 现代中西医结合杂志, 2017, 26(23):2572-2574.
[37] 郝良玉.聚桂醇注射与单纯置管引流治疗盆腔淋巴囊肿的疗效对比[J].内蒙古医学杂志, 2015,47(11):1356-1357.
[38] FERNANDES A S, COSTA A, MOTA R, et al. Bleomycin sclerotherapy for severe symptomatic and persistent pelvic lymphocele[J]. Case Rep Obstet Gynecol, 2014, 2014:624803.
[39] 黄思哲, 易玉萍, 张瑛, 等. 超声介入治疗妇科恶性肿瘤术后盆腔淋巴囊肿的疗效分析[J]. 实用妇科内分泌杂志(电子版), 2018, 5(33):91, 93.
[40] GUPTA R T,BRYAN SEXTON J,MILNE J,et al.Practice and quality improvement:successful implementation of Team STEPPS tools into an academic interventional ultrasound practice[J].Am J Roentgenol, 2015, 204(1):105-110.
[41] LIU J X,ZHANG H X,DU Q Q,et al.Successful laparoscopic treatment of chylous ascites after pelvic lymphadenectomy:a case report and peanut oil application[J]. Minim Invasive Gynecol, 2018,25(5):923-926.